Skip to content

To See The Effect Of Drakshadi Leha And Its Modified Dosage Form i.e.gummies in Patient Of Pandu(IDA)

Development of a New Dosage Form (Gummies) From The Content OF The Drakshadi Leha And its Comapartive Pharmaceutical, Analytical, Stability and Pilot Study Of Both Dosage Forms in Pandu With Special Refernce to Iron Deficiency Anaemia - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084663
Enrollment
30
Registered
2025-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Sponsors

Institute For Ayurved Studies And Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS HAVING DIAGNOSTIC CRITERIA OF PANDU ROG AND IRON DEFICIENCY ANEMIA OF MILD AND MODERATE TYPES (HB RANGE BETWEEN 8-11GM/DL) WILL BE INCLUDED

Exclusion criteria

Exclusion criteria: Patient Below Age 25 And Above Age 45 years. Anemia Other Than IDA. Patients Of Acute Blood Loss. Anemia Due To Leukemia And Other Malignant Disorders. Patients With History Of Other Systemic Diseases Such As Diabetes Mellitus, Hypertension, Renal Failure,CVD Etc. Pregnant And Lactating Women.

Design outcomes

Primary

MeasureTime frame
THEIR IS FORMATION OF GUMMY WHICH IS OF GOOD CONSISTANCY AND WITH GOOD STABILITY AND EFFICACYTimepoint: The patient will be assessed at 31st day i.e. one month.

Secondary

MeasureTime frame
THE GUMMIES AND DRAKSHADI LEHA SHOWED GOOD RESULTS IN IMPROVING THE ANEMIC CONDITIONS. GUMMIES EXPLORE THE IMPLICIT BENEFITS OF TASTE MASKING, DONTS HAVE UNUSUAL SMELL AND ALSO PEDIATRICS, GERIATRICS AS WELL AS PATIENTS ASSOCIATED WITH TOOTH ISSUES CAN EASILY CONSUME GUMMIES. ALSO, THE PRODUCT CAN BE TAKEN EVERYWHERE AND AT ANY TIME AS IT DOES NOT BEAR LIQUIDS TO PROP SWALLOWING.Timepoint: The patient will be assessed at 31st day i.e. one month.

Countries

India

Contacts

Public ContactDR ARCHANA

Institute For Ayurved Studies And Research

drvidushityagi@gmail.com9355021406

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026